Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of 1HP tuberculosis preventive therapy in adults with HIV-associated cryptococcal meningitis
ISRCTN18437550Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rifapentine and isoniazid in Tuberculosis (TB), cryptococcal meningitis and human immunodeficiency virus infection (HIV) (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Started Nov 2021; status: completed.
02
Drugs
rifapentineisoniazid
03
Conditions
Tuberculosis (TB)cryptococcal meningitishuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN18437550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18437550.